Effects of graphene oxide nanosheets on ultrastructure and biophysical properties of pulmonary surfactant film
a Bao Jiao, a Xinghua Shi, a Russell P. Valle, b Yi Y. Zuo* b and Guoqing Hu* a Graphene oxide (GO) is the most common derivative of graphene and has been used in a large range of biomedical applications. Despite considerable progress in understanding its cytotoxicity, its potential inhalation toxicity is still largely unknown. As the pulmonary surfactant (PS) film is the first line of host defense, interaction with the PS film determines the fate of inhaled nanomaterials and their potential toxicity. Using a coarse-grained molecular dynamics model, we reproted, for the first time, a novel mechanism of toxocity caused by inhaled GO nanosheets. Upon depositing, GO nanosheets induce pores in the PS film and thus have adverse effects on the ultrastructure and biophysical properties of the PS film. Notably, the pore induced by GO nanosheets results in increasing compressibility of the PS film, which is an important indication of surfactant inhibition. In vitro experiments have also been conducted to study interactions between GO and animal-derived natural PS films, qualitatively confirming the simulation results.
Graphene oxide is a derivative of graphene containing different levels of reactive oxygen functional groups. With its water solubility, functionalizability, and fluorescence quenching ability, 1-4 GO is a better candidate than the pristine graphene for many biological applications such as diagnostics, imaging, and drug delivery. [5] [6] [7] [8] [9] [10] Therefore, there is a general biosafety concern for human exposure to GO. 11, 12 Many in vitro studies have investigated the cytotoxicity of GO using different cell lines. It has been shown that the toxicity of GO depends not only on dose, [13] [14] [15] but also on its size, shape, number of layers, carbon/oxygen ratio, the density of oxide function groups on the surface, and the tested cell lines. [16] [17] [18] [19] The respiratory tract is one of the most likely paths for GO to enter the body. In vivo studies showed that GO predominantly deposited in the lungs, 20 and exposure to GO causes dosedependent pulmonary inflammation, 21, 22 indicating that GO inhalation may have adverse health impacts. Due to their small size, a large portion of inhaled GO nanosheets can get through the airways and deposit in deep lung, where the GO nanosheets must first interact with the pulmonary surfactant (PS) film at the alveolar surface. 23, 24 The PS is a detergent-like substance composed of approximately 90% lipids, mostly phospholipids, and 10% proteins. 25, 26 It plays a dual role of host defense and biophysical surface tension reduction in the lung. 25 Studies have showed that interactions between nanoparticles (NPs) and the PS film inactivate the biophysical function of PS. [27] [28] [29] [30] [31] [32] Our previous molecular dynamics simulations showed that depending on their physicochemical properties, the NPs may be trapped and wrapped by the PS film, or translocate across it. 29 Regardless of the translocation status, the pristine NPs will be coated with a biomolecular corona and biophysical properties of the PS film can be significantly compromised. 29, 30, 33 It was also found that the shape of nanomaterials strongly impacts their interaction with biomembranes as fullerene, graphene and carbon nanotube show distinctly different translocation behaviors. 30, [34] [35] [36] [37] [38] Therefore, it is not unexpected that GO, being a 2D nanomaterial, interacts with the PS film differently from spherical NPs studied in our previous work.
Here, we studied the interaction mechanisms between PS films and GO nanosheets, using coarse-grained molecular dynamics (CGMD) simulations. We established a detailed model of the PS monolayer film containing phospholipids, cholesterol, and surfactant-associated proteins. As for the GO nanosheets, we considered mono-and trilayer square GO in different sizes. We also conducted in vitro experiments to examine interactions between GO and animal-derived natural PS films. Both in silico and in vitro results consistently showed that GO nanosheets were stranded in the PS monolayer, and thus have adverse effects on the structure and properties of PS film, including increasing the compressibility of PS films, which is an important criterion of evaluating biophysical inhibition of PS.
In our CGMD simulations, the MARTINI force field 39 was used. Four types of GO nanosheets were considered: 5×5 nm 2 monolayer, 5×5 nm 2 trilayer, 10×10 nm 2 monolayer, and 10×10 nm 2 trilayer. The PS monolayer in our simulation consists of dipalmitoyl phosphatidylcholine (DPPC) and palmitoyl-oleoyl phosphatidylglycerol (POPG) with a 7:3 molar ratio, doped with 10 wt % cholesterol, 1.6 wt % surfactant protein (SP)-B, and 1.5 wt % SP-C. To simulate inhalation, we allowed the GO nanosheet to naturally deposit from air onto the preequilibrium PS monolayer. The water slab is 10 nm in thickness, containing Na + ions to neutralize the system. The size of the simulation box is 49×49×50 nm 3 . Boundaries in the z-direction are set as wall, and periodic boundary conditions are used for the x and y directions. Fig. 1 illustrates the CGMD models and simulation system setup. More details of the CG models and the simulation setup are included in the Electronic Supporting Information (ESI), along with Fig. S1 and S2. The interactions were simulated more than 300 ns. The Berendsen barostat was used for the semi-isotropic pressure coupling with a coupling constant τ P = 4 ps. The system compressibility was set to be 5×10 -5 bar -1 in the x-y plane and 0 in the z-direction. The temperature was maintained at 293 K by Berendsen temperature coupling with a coupling constant τ T = 1 ps. The time step was 20 fs. The neighbour list was updated every 10 steps.
As shown in Fig. 2 , all four types of GO nanosheets display similar behaviors interacting with the PS film. The nanosheet lies down quickly after contacting the film (Fig. S3 in the ESI shows that this behaviour always happens despite the different initial orientations of the GO nanosheets). After initial deposit, the GO nanosheet remains at the PS film without penetration. Most importantly, we found that the GO nanosheet induces a pore in the PS film. This pore-inducing process ends in just tens of nanoseconds, and after that the area and shape of the pore hardly change in the subsequent hundreds of nanoseconds. Fig. 3 shows the details of the pore formation in the GO-PS system. (Please also refer to the Supplementary Movie.) The lipids near the original pore edge are pushed away rather than being squeezed to the water. This indicates that, except the direct impact on the PS film by depositing and interacting with molecules around the contact point, the GO nanosheet alters the PS film locally as it compresses the monolayer to a certain extent. The lipid molecules around the GO nanosheet lie down with their hydrophilic head groups facing towards the pore edge of the GO nanosheet. This change of lipid orientation will be discussed later.
In our previous work 29 nanosheet is hydrophilic and thus trends to penetrate the PS membrane and contact water beneath. However, the unique 2D structure of the GO nanosheet makes it lie down quickly upon contacting the PS film. Hence, translocation across the PS monolayer film needs to overcome a very high energy barrier by pushing away a large amount of lipid molecules in the monolayer. The balance of the hydrophilic force and the energy barrier results in the final retention of the GO nanosheet at the PS with an induced pore, as shown in Fig. 3 . This could be a reason why inhaled GO has a prolonged lifetime in the lung as in vivo studies showed. 21, 22 The order parameter that expresses the fatty acid tails' consistency with the perpendicular is generally used to reflect the phase coexistence and transition of the PS film. 40, 41 As shown in Fig. 4(a,b) , the order parameters are used to color the areas of corresponding molecules in a Voronoi diagram. The average data of different beads in DPPC is shown in Fig.  4(c) . Details about the calculation of the order parameters are included in the ESI. Lipids near the induced pore, as they lie down on the GO nanosheet ( Fig. 3 ), exhibit very low order parameters. While in area away from the GO nanosheet, the order parameters follow a normal composite distribution. GO nanosheets hardly change the overall order parameters. Therefore, it can be concluded that the GO nanosheet affects the phase behavior of the PS film significantly only in the local range. The radial distribution function is analyzed in the ESI, also showing that GO nanosheets have little impact on the overall phase behavior of the PS film. The PS should adsorb rapidly to expand the film at the air-water interface during inhalation. 25, 42 Diffusion coefficients are used to show the liquidity of the PS film quantitatively ( Fig.4(d) ). For all five PS components, all types of GO nanosheets reduce the diffusion coefficients by at least one order of magnitude, which implies that the liquidity of PS is significantly limited by GO. Note that the diffusion coefficients show no obvious difference, regardless of the lateral size and number of layers of these four types of GO nanosheets. Please do not adjust margins
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To confirm the phenomena of GO-induced pores in the PS monolayer film, we have investigated interaction between the PS film and reduced-GO. Reduced-GO with half oxide groups stays on the monolayer without pore induced. Order parameters and diffusion coefficients of reduced-GO-affected PS film are much more similar to those of a pure PS film rather than those of a GO-affected PS as shown in Fig. S6 in the ESI. Therefore, we believe that it is the pore not the GO itself affects the monolayer properties directly.
We have also conducted in vitro experiments to study interactions between GO and animal-derived natural PS films. Experiments on the interaction between Infasurf (calfactant) and GO nanosheets were conducted using a Langmuir-Blodgett trough. 27 Experimental details of interactions between Infasurf (calfactant) and GO nanosheets are provided in the ESI. It is found that GO nanosheets adsorb onto the PS film, with the nanosheet partially covered by lipid molecules (Fig. 5(a-c) , see Fig. S7 for more AFM images). This agrees with our in silico simulations. Furthermore, compared with the pure Infasurf, obvious reduction in domain formation can be found in the GO-containing Infasurf, indicating disruption of the monolayer ultrastructure. Typical compression-expansion cycles of pure Infasurf and Infasurf mixed with GO were compared using the constrained drop surfactometer 30 (Fig. 5(d) ). GO nanosheets significantly increased the hysteresis area, which indicates film instability and surfactant inhibition. 43 The film compressibility is significantly increased, which is an important indication of surfactant inhibition. 44 Upon film compression during exhalation, a good surfactant film should have a low compressibility, thus decreasing the surface tension to nearzero with less than 20% area compression. 25 Higher compressibility means that more area compression is needed to achieve a low surface tension, leading to respiratory failure. Although having much smaller length and time scales, CGMD simulations show a qualitatively consistent result for the increasing compressibility after exposure to GO. PS films with and without a GO nanosheet were equilibrated at different membrane areas. It is found that when the side length of the membrane area is decreased from 493 Å to 488 Å, the surface tension of the pure PS decreases by 5.0 mN/m, while the PS film affected by GO only decreases surface tension by 4.1 mN/m. This indicates that the compressibility of the GO-affected PS film is about 20% larger than that of the pure PS film. Besides, it is found that the pore induced by GO disappears when the membrane area is decreased, suggesting a likely correlation between the induced pore and the increasing compressibility of the PS film.
In summary, using CGMD simulation and experimental measurement, we illustrate the interactions between the PS monolayer films and the GO nanosheets. We report retention and adverse biophysical impact of GO on the PS film. The GO nanosheets induce pores on the monolayer film, and affect its biophysical properties. Remarkably, GO nanosheets increase the compressibility of PS films, which indicates the biophysical inhibition of PS. We provide a new perspective to understand the inhalation toxicity of the GO nanosheet by studying its interaction with the PS film.
